Abstract 2550: N-terminal Pro-brain Natriuretic Peptide-defined Cardiomyopathy in Doxorubicin-treated Children with Acute Lymphoblastic Leukemia
Steven E. Lipshultz(Jacobs Institute), Stephen E. Sallan, Luis A. Clavell(San Juan City Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Nader Rifai(Harvard University), Richard D. Gelber(Harvard University), Elly Barry, Uma H. Athale(McMaster University), Lewis B. Silverman(Columbia University Irving Medical Center), Albert Moghrabi(Centre Hospitalier Universitaire Sainte-Justine), Barbara L. Asselin(University of Rochester Medical Center), Stuart R. Lipsitz(Brigham and Women's Hospital), Rebecca E. Scully(Brigham and Women's Hospital), Yvan Samson(Centre hospitalier universitaire de Québec), Virginia Dalton(Dana-Farber Cancer Institute), Steven D. Colan(Boston Children's Hospital), Tracie L. Miller(University of Missouri–Kansas City), Marshall A. Schorin(Inova Fairfax Hospital)
Cited by 5
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
|Circulation|2003|2.3k